Agree, even thought ADAPT has been clinically proven to provide the most durable valve technology on the market there wasn't a point of difference with the other product which had less durability, TAVR now being prefer method of heart surgery for younger patient is the game changer so valve durability is a very important point of difference when comparing other product on the market.
Agree, even thought ADAPT has been clinically proven to provide...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.81 |
Change
0.260(1.33%) |
Mkt cap ! $380.7M | |||
| Open | High | Low | Value | Volume |
| $19.55 | $20.50 | $19.50 | $457.3K | 22.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $19.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.81 | 978 | 2 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.10 |
Change
0.260 ( 2.71 %) |
||||
| Open | High | Low | Volume | ||
| $19.99 | $20.10 | $19.91 | 302 | ||
| Last updated 12.44pm 21/05/2024 ? | |||||
| AVR (ASX) Chart |